Assembly Biosciences (ASMB) Change in Account Payables (2014 - 2026)
Assembly Biosciences (ASMB) posted quarterly Change in Account Payables of -$42000.0 for Q1 2026, down 114.48% year-over-year from $290000.0 in Q1 2025, and up 91.8% quarter-over-quarter from -$512000.0 in Q4 2025.
Assembly Biosciences (ASMB) Change in Account Payables (2014 - 2026) Analysis & Trends
Assembly Biosciences' Change in Account Payables history runs 13 years deep, the most recent figure standing at -$42000.0 for Q1 2026.
- In Q1 2026, Change in Account Payables fell 114.48% year-over-year to -$42000.0; the TTM figure through Mar 2026 stood at $254000.0 (up 71.62% YoY), while the FY2025 annual figure was $586000.0, up 372.58% from the prior year.
- Change in Account Payables for Q1 2026 stood at -$42000.0, up from -$512000.0 in the prior quarter.
- The five-year high for Change in Account Payables was $1.0 million in Q2 2022, with the low at -$1.3 million in Q1 2023.
- The 5-year median for Change in Account Payables is -$132000.0 (2025), against an average of -$90000.0.
- The sharpest annual moves came in 2022 and 2025: Change in Account Payables soared 1677.42% in 2022, then tumbled 278.38% in 2025.
- Assembly Biosciences' Change in Account Payables stood at $551000.0 in 2022, then sank by 153.9% to -$297000.0 in 2023, then sank by 152.53% to -$750000.0 in 2024, then jumped by 31.73% to -$512000.0 in 2025, then soared by 91.8% to -$42000.0 in 2026.
- Business Quant data shows ASMB's Change in Account Payables at -$42000.0 in Q1 2026, -$512000.0 in Q4 2025, and $940000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.03 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 37.53 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 520,137.79 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Assembly Biosciences | 670.88 Mn | 350.52 Mn | - | -70,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -70,000.00 |
| Jun 30, 2026 | -70,000.00 |
| Mar 31, 2026 | -42,000.00 |
| Mar 31, 2026 | -42,000.00 |
| Dec 31, 2025 | -512,000.00 |
| Dec 31, 2025 | -512,000.00 |
| Sep 30, 2025 | 940,000.00 |
| Sep 30, 2025 | 940,000.00 |
| Jun 30, 2025 | -132,000.00 |
| Jun 30, 2025 | -132,000.00 |
| Mar 31, 2025 | 290,000.00 |
| Mar 31, 2025 | 290,000.00 |
| Dec 31, 2024 | -750,000.00 |
| Dec 31, 2024 | -750,000.00 |
| Sep 30, 2024 | 534,000.00 |
| Sep 30, 2024 | 534,000.00 |
| Jun 30, 2024 | 74,000.00 |
| Jun 30, 2024 | 74,000.00 |
| Mar 31, 2024 | 266,000.00 |
| Mar 31, 2024 | 266,000.00 |